| Literature DB >> 24964346 |
Jean Borges Bertoldo1, Louise Domeneghini Chiaradia-Delatorre, Alessandra Mascarello, Paulo César Leal, Marlon Norberto Sechini Cordeiro, Ricardo José Nunes, Emir Salas Sarduy, Philip Jon Rosenthal, Hernán Terenzi.
Abstract
Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many previous studies have identified FP-2 inhibitors; however, none has yet met the criteria for an antimalarial drug candidate. In this work, we assayed an in-house library of non-peptidic organic compounds, including (E)-chalcones, (E)-N'-benzylidene-benzohydrazides and alkyl-esters of gallic acid, and assessed the activity toward FP-2 and their mechanisms of inhibition. The (E)-chalcones 48, 54 and 66 showed the lowest IC50 values (8.5 ± 0.8 µM, 9.5 ± 0.2 µM and 4.9 ± 1.3 µM, respectively). The best inhibitor (compound 66) demonstrated non-competitive inhibition, and using mass spectrometry and fluorescence spectroscopy assays, we suggest a potential allosteric site for the interaction of this compound, located between the catalytic site and the hemoglobin binding arm in FP-2. We combined structural biology tools and mass spectrometry to characterize the inhibition mechanisms of novel compounds targeting FP-2.Entities:
Keywords: Chalcones; Plasmodium falciparum; falcipain-2 inhibitors; malaria
Mesh:
Substances:
Year: 2014 PMID: 24964346 DOI: 10.3109/14756366.2014.920839
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051